1. Multimodality treatmentof stage III NSCLC Jan P van Meerbeeck EIS-Geneva 2. Are you « out »when not offering your patientconcurrent chemoradiotherapy? 3. Evidence-based…
Abstract:148 Frontline Therapy with the RiBVD Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final…